Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-3-17
pubmed:abstractText
In bovine aortic endothelial cells (BAECs), we previously demonstrated B1 and B2 kinin receptor-mediated increases in intracellular guanosine-3',5'-cyclic monophosphate (cGMP). In this study, the B2 kinin receptor agonist bradykinin increased cGMP in rat microvascular coronary endothelial cells (RMCECs) and human umbilical vein endothelial cells (HUVECs), which could be prevented with the specific B2 kinin receptor antagonist icatibant but not with the B1 kinin receptor antagonist des-Arg9-[Leu8]bradykinin or with the nonpeptide kinin receptor antagonist WIN 64338. B2 kinin receptor mRNA could be detected in all three cell types using reverse transcription-polymerase chain reaction and subsequent Southern blotting. The B1 kinin receptor agonist des-Arg9-bradykinin increased cGMP in RMCECs but not in HUVECs. The response in RMCECs could be prevented by des-Arg9-[Leu8]bradykinin as well as by WIN 64338 but not by icatibant. In BAECs, the B1 kinin receptor-mediated cGMP synthesis could be prevented by icatibant and desensitized by preincubation with des-Arg9-bradykinin as well as bradykinin. We detected B1 kinin receptor mRNA in RMCECs and HUVECs but not in BAECs. In HUVECs, the detection of B1 kinin receptor mRNA is in contradiction to the cGMP measurements. In BAECs, the atypical B1 kinin receptor pharmacology, the heterologous desensitization of the receptor and the failure to detect B1 kinin receptor mRNA cannot be explained by a typical B1 kinin receptor subtype. Thus, B2 kinin receptors with similar pharmacology are constitutively expressed in each of the three endothelial cell types. However, the endothelial cell types are heterogeneous in the expression of typical B1 kinin receptors and the pharmacology of the B1 kinin receptor-mediated responses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1109-16
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9023330-Animals, pubmed-meshheading:9023330-Aorta, pubmed-meshheading:9023330-Bradykinin, pubmed-meshheading:9023330-Cattle, pubmed-meshheading:9023330-Cells, Cultured, pubmed-meshheading:9023330-Coronary Vessels, pubmed-meshheading:9023330-Cyclic GMP, pubmed-meshheading:9023330-DNA Primers, pubmed-meshheading:9023330-Endothelium, Vascular, pubmed-meshheading:9023330-Humans, pubmed-meshheading:9023330-Microcirculation, pubmed-meshheading:9023330-Naphthalenes, pubmed-meshheading:9023330-Organophosphorus Compounds, pubmed-meshheading:9023330-Polymerase Chain Reaction, pubmed-meshheading:9023330-Rats, pubmed-meshheading:9023330-Receptor, Bradykinin B1, pubmed-meshheading:9023330-Receptors, Bradykinin, pubmed-meshheading:9023330-Species Specificity, pubmed-meshheading:9023330-Transcription, Genetic, pubmed-meshheading:9023330-Umbilical Veins
pubmed:year
1997
pubmed:articleTitle
Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species.
pubmed:affiliation
Hoechst-Marion-Roussel, Disease Group Cardiovascular, Frankfurt, Germany.
pubmed:publicationType
Journal Article